Purchase Order HHSN272201501033P
Award Date 8/10/15
Potential Completion Date 8/17/15
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award, valued at $5,277.25, is for the provision of sequencing kits to support NIAID's research and diagnostics work. Illumina has been a long-standing provider of sequencing solutions to various federal agencies including the Centers for...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $5,212.06 contract is for the provision of next-generation sequencing kits to support genomic research and diagnostics. Illumina has a history of providing sequencing systems, reagents, and associated services to federal agencies...
- This is a $85,850.73 firm fixed price delivery order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award is for the provision of ILLUMINA NEXTSEQ 1000 and 2000 sequencing kits and does not utilize a set-aside. Illumina is a leading manufacturer of sequencing instruments and consumables, and has a history of providing these products to federal agencies for genomic research...
- This is a $7,460.28 firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for Illumina's NextSeq 500/550 High Output Kit V2 (150 cycles), with a completion date of July 15, 2017. There is no set-aside designation for this award. Illumina has previously received prime federal contract and...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina sequencing instruments and related consumables and support services. The $3,753.75 order is part of a larger Indefinite Delivery Contract held by Illumina with the Department of the Navy Bureau of Medicine and Surgery, which supports nucleic acid sequencing needs at the Naval...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer and provider of genetic and genomic analysis solutions. The $5,834.40 order is for the provision of Illumina's sequencing instruments, reagents, and services, including NextSeq, NovaSeq, MiSeq, and iSeq systems. These products and services support genomic sequencing and analysis for...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $142,137.54 award is for the provision of NextSeq, MiSeq, and NextSeq High Output kits to support genomic analysis and research. This contract does not have a set-aside designation. Illumina has a history of providing...